<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37565145</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-042X</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in physiology</Title><ISOAbbreviation>Front Physiol</ISOAbbreviation></Journal><ArticleTitle>Hematological alterations associated with long COVID-19.</ArticleTitle><Pagination><StartPage>1203472</StartPage><MedlinePgn>1203472</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1203472</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphys.2023.1203472</ELocationID><Abstract><AbstractText>Long COVID-19 is a condition characterized by persistent symptoms lasting beyond the acute phase of COVID-19. Long COVID-19 produces diverse symptomatology and can impact organs and systems, including the hematological system. Several studies have reported, in COVID-19 patients, hematological abnormalities. Most of these alterations are associated with a higher risk of severe disease and poor outcomes. This literature review identified studies reporting hematological parameters in individuals with Long COVID-19. Findings suggest that Long COVID-19 is associated with a range of sustained hematological alterations, including alterations in red blood cells, anemia, lymphopenia, and elevated levels of inflammatory markers such as ferritin, D-dimer, and IL-6. These alterations may contribute to a better understanding of the pathophysiology of Long COVID-19 and its associated symptoms. However, further research is needed to elucidate the underlying mechanisms and potential treatments for these hematological changes in individuals with Long COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Lechuga, Morel and De-Simone.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lechuga</LastName><ForeName>Guilherme C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Center for Technological Development in Health (CDTS)/ National Institute of Science and Technology for Innovation in Neglected Population Diseases (INCT-IDPN), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Epidemiology and Molecular Systematics (LESM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Cellular Ultrastructure, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morel</LastName><ForeName>Carlos M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Center for Technological Development in Health (CDTS)/ National Institute of Science and Technology for Innovation in Neglected Population Diseases (INCT-IDPN), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De-Simone</LastName><ForeName>Salvatore Giovanni</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Center for Technological Development in Health (CDTS)/ National Institute of Science and Technology for Innovation in Neglected Population Diseases (INCT-IDPN), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Epidemiology and Molecular Systematics (LESM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Post-Graduation Program in Science and Biotechnology, Department of Molecular and Cellular Biology, Biology Institute, Federal Fluminense University, Niter&#xf3;i, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Physiol</MedlineTA><NlmUniqueID>101549006</NlmUniqueID><ISSNLinking>1664-042X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">hematology</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">post-acute sequelae</Keyword><Keyword MajorTopicYN="N">red blood cells</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>4</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37565145</ArticleId><ArticleId IdType="pmc">PMC10411895</ArticleId><ArticleId IdType="doi">10.3389/fphys.2023.1203472</ArticleId><ArticleId IdType="pii">1203472</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Saadi E. A. K. D., Abdulnabi M. A. (2022). Hematological changes associated with COVID-19 infection. J. Clin. Lab. Anal. 36, e24064. 10.1002/jcla.24064</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.24064</ArticleId><ArticleId IdType="pmc">PMC8646489</ArticleId><ArticleId IdType="pubmed">34783405</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfadda A. A., Rafiullah M., Alkhowaiter M., Alotaibi N., Alzahrani M., Binkhamis K., et al. (2022). Clinical and biochemical characteristics of people experiencing post-coronavirus disease 2019-related symptoms: A prospective follow-up investigation. Front. Med. (Lausanne) 9, 1067082. 10.3389/fmed.2022.1067082</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1067082</ArticleId><ArticleId IdType="pmc">PMC9763306</ArticleId><ArticleId IdType="pubmed">36561720</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Mashdali A. F., Ata Y. M., Yassin M. A. (2021). Concomitant autoimmune hemolytic anemia and pulmonary embolism associated with mild COVID&#x2010;19: A case report. Clin. Case Rep. 9, e04952. 10.1002/ccr3.4952</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.4952</ArticleId><ArticleId IdType="pmc">PMC8521316</ArticleId><ArticleId IdType="pubmed">34703600</ArticleId></ArticleIdList></Reference><Reference><Citation>Anai M., Akaike K., Iwagoe H., Akasaka T., Higuchi T., Miyazaki A., et al. (2021). Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia. Respir. Investig. 59, 187&#x2013;193. 10.1016/J.RESINV.2020.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.RESINV.2020.10.009</ArticleId><ArticleId IdType="pmc">PMC7682330</ArticleId><ArticleId IdType="pubmed">33281114</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., et al. (2022). Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 28, 611.e9&#x2013;611611.e16. 10.1016/j.cmi.2021.11.002-</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza M. T., Jeney V. (2020). Pro-inflammatory actions of heme and other hemoglobin-derived DAMPs. Front. Immunol. 11, 1323. 10.3389/fimmu.2020.01323</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01323</ArticleId><ArticleId IdType="pmc">PMC7339442</ArticleId><ArticleId IdType="pubmed">32695110</ArticleId></ArticleIdList></Reference><Reference><Citation>Brundyn J. L., Gillan J., Singh I. (2022). Hematologic abnormalities associated with post-acute COVID-19 sequelae or &#x201c;long-COVID&#x201d;-a systematic review. Int. J. Bio. Lab. Sci. 11 (1), 23&#x2013;42.</Citation></Reference><Reference><Citation>Caruso D., Guido G., Zerunian M., Polidori T., Lucertini E., Pucciarelli F., et al. (2021). Post-acute sequelae of COVID-19 pneumonia: Six-month chest CT follow-up. Radiology 301, E396&#x2013;E405. 10.1148/radiol.2021210834</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210834</ArticleId><ArticleId IdType="pmc">PMC8335814</ArticleId><ArticleId IdType="pubmed">34313468</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavezzi A., Troiani E., Corrao S. (2020). COVID-19: Hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin. Pract. 10, 1271. 10.4081/cp.2020.1271</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/cp.2020.1271</ArticleId><ArticleId IdType="pmc">PMC7267810</ArticleId><ArticleId IdType="pubmed">32509258</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S. H., Minn D., Kim S. W., Kim Y. K. (2021). Inflammatory markers and cytokines in moderate and critical cases of COVID-19. Clin. Lab. 67 (9). 10.7754/Clin.Lab.2021.210142</Citation><ArticleIdList><ArticleId IdType="doi">10.7754/Clin.Lab.2021.210142</ArticleId><ArticleId IdType="pubmed">34542974</ArticleId></ArticleIdList></Reference><Reference><Citation>Churilov L. P., Normatov M. G., Utekhin V. J. (2022). Molecular mimicry between SARS-CoV-2 and human endocrinocytes: A prerequisite of post-COVID-19 endocrine autoimmunity? Pathophysiology 29, 486&#x2013;494. 10.3390/pathophysiology29030039</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathophysiology29030039</ArticleId><ArticleId IdType="pmc">PMC9504401</ArticleId><ArticleId IdType="pubmed">36136066</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosic I., Cosic D., Loncarevic I. (2020). RRM prediction of erythrocyte Band3 protein as alternative receptor for SARS-CoV-2 virus. Appl. Sci. 10, 4053. 10.3390/app10114053</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app10114053</ArticleId></ArticleIdList></Reference><Reference><Citation>Cueto-Robledo G., Porres-Aguilar M., Puebla-Aldama D., Barrag&#xe1;n-Mart&#xed;nez M., del P., Jurado-Hern&#xe1;ndez M. Y., et al. (2022). Severe pulmonary hypertension: An important sequel after severe post-acute COVID-19 pneumonia. Curr. Probl. Cardiol. 47, 101004. 10.1016/j.cpcardiol.2021.101004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2021.101004</ArticleId><ArticleId IdType="pmc">PMC8482545</ArticleId><ArticleId IdType="pubmed">34601005</ArticleId></ArticleIdList></Reference><Reference><Citation>Darcis G., Bouquegneau A., Maes N., Thys M., Henket M., Labye F., et al. (2021). Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: A monocentric prospective observational cohort study. Int. J. Infect. Dis. 109, 209&#x2013;216. 10.1016/j.ijid.2021.07.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.07.016</ArticleId><ArticleId IdType="pmc">PMC8278829</ArticleId><ArticleId IdType="pubmed">34273510</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., Assaf G. S., McCorkell L., Wei H., Low R. J., Re&#x2019;em Y., et al. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., McCorkell L., Vogel J. M., Topol E. J. (2023). Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133&#x2013;146. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Diederich L., Suvorava T., Sansone R., Keller T. C. S., Barbarino F., Sutton T. R., et al. (2018). On the effects of reactive oxygen species and nitric oxide on red blood cell deformability. Front. Physiol. 9, 332. 10.3389/fphys.2018.00332</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00332</ArticleId><ArticleId IdType="pmc">PMC5958211</ArticleId><ArticleId IdType="pubmed">29867516</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan B. E., Wong S. W., Sum C. L. L., Lim G. H., Leung B. P., Tan C. W., et al. (2022). Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: Assessing the long&#x2010;term outcomes in COVID&#x2010;19 patients. Am. J. Hematol. 97, 915&#x2013;923. 10.1002/ajh.26575</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26575</ArticleId><ArticleId IdType="pmc">PMC9073976</ArticleId><ArticleId IdType="pubmed">35477923</ArticleId></ArticleIdList></Reference><Reference><Citation>Fattizzo B., Pasquale R., Bellani V., Barcellini W., Kulasekararaj A. G. (2021). Complement mediated hemolytic anemias in the COVID-19 era: Case series and review of the literature. Front. Immunol. 12, 791429. 10.3389/fimmu.2021.791429</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.791429</ArticleId><ArticleId IdType="pmc">PMC8655106</ArticleId><ArticleId IdType="pubmed">34899761</ArticleId></ArticleIdList></Reference><Reference><Citation>
Gajendra S. (2022). Spectrum of hematological changes in COVID-19. Available at: www.AJBlood.us/.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8918700</ArticleId><ArticleId IdType="pubmed">35291254</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganz T. (2011). Hepcidin and iron regulation, 10 years later. Blood 117, 4425&#x2013;4433. 10.1182/blood-2011-01-258467</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-01-258467</ArticleId><ArticleId IdType="pmc">PMC3099567</ArticleId><ArticleId IdType="pubmed">21346250</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillespie A. H., Doctor A. (2021). Red blood cell contribution to hemostasis. Front. Pediatr. 9, 629824. 10.3389/fped.2021.629824</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.629824</ArticleId><ArticleId IdType="pmc">PMC8047051</ArticleId><ArticleId IdType="pubmed">33869111</ArticleId></ArticleIdList></Reference><Reference><Citation>Girelli D., Marchi G., Busti F., Vianello A. (2021). Iron metabolism in infections: Focus on COVID-19. Semin. Hematol. 58, 182&#x2013;187. 10.1053/j.seminhematol.2021.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.seminhematol.2021.07.001</ArticleId><ArticleId IdType="pmc">PMC8305218</ArticleId><ArticleId IdType="pubmed">34389110</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E. L., Clark J. R., Orban Z. S., Lim P. H., Szymanski A. L., Taylor C., et al. (2021). Persistent neurologic symptoms and cognitive dysfunction in non&#x2010;hospitalized Covid&#x2010;19 long haulers. Ann. Clin. Transl. Neurol. 8, 1073&#x2013;1085. 10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Grau M., Ibershoff L., Zacher J., Bros J., Tomschi F., Diebold K. F., et al. (2022). Even patients with mild COVID&#x2010;19 symptoms after SARS&#x2010;CoV&#x2010;2 infection show prolonged altered red blood cell morphology and rheological parameters. J. Cell Mol. Med. 26, 3022&#x2013;3030. 10.1111/jcmm.17320</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.17320</ArticleId><ArticleId IdType="pmc">PMC9097836</ArticleId><ArticleId IdType="pubmed">35419946</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregorova M., Morse D., Brignoli T., Steventon J., Hamilton F., Albur M., et al. (2020). Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. Elife 9, e63430. 10.7554/eLife.63430</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.63430</ArticleId><ArticleId IdType="pmc">PMC7775105</ArticleId><ArticleId IdType="pubmed">33331820</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Benito Ballesteros A., Yeung S. P., Liu R., Saha A., Curtis L., et al. (2022). Covcog 2: Cognitive and memory deficits in long COVID: A second publication from the COVID and cognition study. Front. Aging Neurosci. 14, 804937. 10.3389/fnagi.2022.804937</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.804937</ArticleId><ArticleId IdType="pmc">PMC8967943</ArticleId><ArticleId IdType="pubmed">35370620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadj Hassine I. (2022). Covid&#x2010;19 vaccines and variants of concern: A review. Rev. Med. Virol. 32, e2313. 10.1002/rmv.2313</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2313</ArticleId><ArticleId IdType="pmc">PMC8646685</ArticleId><ArticleId IdType="pubmed">34755408</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariyanto T. I., Japar K. V., Kwenandar F., Damay V., Siregar J. I., Lugito N. P. H., et al. (2021). Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis. Am. J. Emerg. Med. 41, 110&#x2013;119. 10.1016/J.AJEM.2020.12.076</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AJEM.2020.12.076</ArticleId><ArticleId IdType="pmc">PMC7831442</ArticleId><ArticleId IdType="pubmed">33418211</ArticleId></ArticleIdList></Reference><Reference><Citation>Haunhorst S., Bloch W., Wagner H., Ellert C., Kr&#xfc;ger K., Vilser D. C., et al. (2022). Long COVID: A narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity. Oxf Open Immunol. 3, iqac006. 10.1093/oxfimm/iqac006</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqac006</ArticleId><ArticleId IdType="pmc">PMC9494493</ArticleId><ArticleId IdType="pubmed">36846561</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kr&#xfc;ger N., Schulz S., Cossmann A., Rocha C., Kempf A., et al. (2022). The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell 185, 447&#x2013;456.e11. 10.1016/j.cell.2021.12.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.12.032</ArticleId><ArticleId IdType="pmc">PMC8702401</ArticleId><ArticleId IdType="pubmed">35026151</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497&#x2013;506. 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Illg Z., Muller G., Mueller M., Nippert J., Allen B. (2021). Analysis of absolute lymphocyte count in patients with COVID-19. Am. J. Emerg. Med. 46, 16&#x2013;19. 10.1016/j.ajem.2021.02.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2021.02.054</ArticleId><ArticleId IdType="pmc">PMC7923864</ArticleId><ArticleId IdType="pubmed">33706251</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs M. M., Evans E., Ellis C. (2023). Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19. J. Natl. Med. Assoc. 115, 233&#x2013;243. 10.1016/j.jnma.2023.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnma.2023.01.016</ArticleId><ArticleId IdType="pmc">PMC9923441</ArticleId><ArticleId IdType="pubmed">36792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalaivani M., Dinakar S. (2022). Association between D-dimer levels and post-acute sequelae of SARS-CoV-2 in patients from a tertiary care center. Biomark. Med. 16, 833&#x2013;838. 10.2217/bmm-2022-0050</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2022-0050</ArticleId><ArticleId IdType="pubmed">35787147</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsten E., Breen E., Herbert B. R. (2018). Red blood cells are dynamic reservoirs of cytokines. Sci. Rep. 8, 3101. 10.1038/s41598-018-21387-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-21387-w</ArticleId><ArticleId IdType="pmc">PMC5814557</ArticleId><ArticleId IdType="pubmed">29449599</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushal K., Kaur H., Sarma P., Bhattacharyya A., Sharma D. J., Prajapat M., et al. (2022). Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis. J. Crit. Care 67, 172&#x2013;181. 10.1016/j.jcrc.2021.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2021.09.023</ArticleId><ArticleId IdType="pmc">PMC8604557</ArticleId><ArticleId IdType="pubmed">34808527</ArticleId></ArticleIdList></Reference><Reference><Citation>Kernan K. F., Carcillo J. A. (2017). Hyperferritinemia and inflammation. Int. Immunol. 29, 401&#x2013;409. 10.1093/intimm/dxx031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxx031</ArticleId><ArticleId IdType="pmc">PMC5890889</ArticleId><ArticleId IdType="pubmed">28541437</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Xia B. T., Jung A. D., Chang A. L., Abplanalp W. A., Caldwell C. C., et al. (2018). Microparticles from stored red blood cells promote a hypercoagulable state in a murine model of transfusion. Surgery 163, 423&#x2013;429. 10.1016/j.surg.2017.09.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2017.09.028</ArticleId><ArticleId IdType="pmc">PMC5780240</ArticleId><ArticleId IdType="pubmed">29198748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronstein-Wiedemann R., Stadtm&#xfc;ller M., Traikov S., Georgi M., Teichert M., Yosef H., et al. (2022). SARS-CoV-2 infects red blood cell progenitors and dysregulates hemoglobin and iron metabolism. Stem Cell Rev. Rep. 18, 1809&#x2013;1821. 10.1007/s12015-021-10322-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-021-10322-8</ArticleId><ArticleId IdType="pmc">PMC8856880</ArticleId><ArticleId IdType="pubmed">35181867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kub&#xe1;nkov&#xe1; M., Hohberger B., Hoffmanns J., F&#xfc;rst J., Herrmann M., Guck J., et al. (2021). Physical phenotype of blood cells is altered in COVID-19. Biophys. J. 120, 2838&#x2013;2847. 10.1016/j.bpj.2021.05.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.05.025</ArticleId><ArticleId IdType="pmc">PMC8169220</ArticleId><ArticleId IdType="pubmed">34087216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y.-J., Liu S.-H., Manachevakul S., Lee T.-A., Kuo C.-T., Bello D. (2023). Biomarkers in long COVID-19: A systematic review. Front. Med. (Lausanne) 10, 1085988. 10.3389/fmed.2023.1085988</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarian G., Quinquenel A., Bellal M., Siavellis J., Jacquy C., Re D., et al. (2020). Autoimmune haemolytic anaemia associated with COVID&#x2010;19 infection. Br. J. Haematol. 190, 29&#x2013;31. 10.1111/bjh.16794</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16794</ArticleId><ArticleId IdType="pmc">PMC7267601</ArticleId><ArticleId IdType="pubmed">32374906</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzaroni M. G., Piantoni S., Masneri S., Garrafa E., Martini G., Tincani A., et al. (2021). Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system. Blood Rev. 46, 100745. 10.1016/j.blre.2020.100745</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2020.100745</ArticleId><ArticleId IdType="pmc">PMC7444609</ArticleId><ArticleId IdType="pubmed">32868115</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal J. K. F., Adjobo-Hermans M. J. W., Bosman G. J. C. G. M. (2018). Red blood cell homeostasis: Mechanisms and effects of microvesicle generation in health and disease. Front. Physiol. 9, 703. 10.3389/fphys.2018.00703</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00703</ArticleId><ArticleId IdType="pmc">PMC6002509</ArticleId><ArticleId IdType="pubmed">29937736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechuga G. C., Souza-Silva F., Sacramento C. Q., Trugilho M. R. O., Valente R. H., Napole&#xe3;o-P&#xea;go P., et al. (2021). SARS-CoV-2 proteins bind to hemoglobin and its metabolites. Int. J. Mol. Sci. 22, 9035. 10.3390/ijms22169035</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22169035</ArticleId><ArticleId IdType="pmc">PMC8396565</ArticleId><ArticleId IdType="pubmed">34445741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann A., Prosch H., Zehetmayer S., Gysan M. R., Bernitzky D., Vonbank K., et al. (2021). Impact of persistent D-dimer elevation following recovery from COVID-19. PLoS One 16, e0258351. 10.1371/journal.pone.0258351</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0258351</ArticleId><ArticleId IdType="pmc">PMC8553152</ArticleId><ArticleId IdType="pubmed">34710097</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H., Liu X., Sun H., Zhang J., Dong S., Liu M., et al. (2022). Sustained abnormality with recovery of COVID-19 convalescents: A 2-year follow-up study. Sci. Bull. (Beijing) 67, 1556&#x2013;1561. 10.1016/j.scib.2022.06.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scib.2022.06.025</ArticleId><ArticleId IdType="pmc">PMC9375590</ArticleId><ArticleId IdType="pubmed">35991002</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S. E., Brown J. S., Denneny E. K., Hare S. S., et al. (2021). &#x2018;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 76, 396&#x2013;398. 10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S., Hosseiniyan Khatibi S. M., Hejazi M. S., Tarhriz V., Farjami A., Ghasemian Sorbeni F., et al. (2022). COVID-19 infection: An overview on cytokine storm and related interventions. Virol. J. 19, 92. 10.1186/s12985-022-01814-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01814-1</ArticleId><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.-M., Andres M., Ramos J. M., Arenas-Jim&#xe9;nez J., et al. (2021). Post-acute COVID-19 syndrome. Incidence and risk factors: A mediterranean cohort study. J. Infect. 82, 378&#x2013;383. 10.1016/j.jinf.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Nader E., Nougier C., Boisson C., Poutrel S., Catella J., Martin F., et al. (2022). Increased blood viscosity and red blood cell aggregation in patients with COVID&#x2010;19. Am. J. Hematol. 97, 283&#x2013;292. 10.1002/ajh.26440</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26440</ArticleId><ArticleId IdType="pubmed">34939698</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I., Schulze A., Evers G., Harmening K., Vink H., K&#xfc;mpers P., et al. (2023). Persistent capillary rarefication in long COVID syndrome. Angiogenesis 26, 53&#x2013;61. 10.1007/s10456-022-09850-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L. (2021). SARS CoV&#x2010;2 related microvascular damage and symptoms during and after COVID&#x2010;19: Consequences of capillary transit&#x2010;time changes, tissue hypoxia and inflammation. Physiol. Rep. 9, e14726. 10.14814/phy2.14726</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E., Corsetti G., Romano C., Scarabelli T. M., Chen-Scarabelli C., Saravolatz L., et al. (2021). Serum metabolic profile in patients with long-covid (PASC) syndrome: Clinical implications. Front. Med. (Lausanne) 8, 714426. 10.3389/fmed.2021.714426</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.714426</ArticleId><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., Palese A., Venturini M., De Martino M., Gerussi V., Graziano E., et al. (2021). Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect. 27, 1507&#x2013;1513. 10.1016/j.cmi.2021.05.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M. J., Deveau T.-M., Munter S. E., Ryder D., Buck A., Beck-Engeser G., et al. (2023). Chronic viral coinfections differentially affect the likelihood of developing long COVID. J. Clin. Investigation 133, e163669. 10.1172/JCI163669</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M. J., Lu S., Tang A. F., Durstenfeld M. S., Ho H., Goldberg S. A., et al. (2021). Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J. Infect. Dis. 224, 1839&#x2013;1848. 10.1093/infdis/jiab490</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira-Roche N., Roblejo-Balbuena H., Mar&#xed;n-Padr&#xf3;n L. C., Izaguirre-Rodr&#xed;guez R., Sotomayor-Lugo F., Z&#xfa;&#xf1;iga-Rosales Y., et al. (2022). Hematological alterations in patients recovered from SARS-CoV-2 infection in havana, Cuba. MEDICC Rev. 24, 7&#x2013;14. 10.37757/mr2022.v24.n2.1</Citation><ArticleIdList><ArticleId IdType="doi">10.37757/mr2022.v24.n2.1</ArticleId><ArticleId IdType="pubmed">35648057</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A., Ara&#xfa;jo-Ameijeiras A., Fern&#xe1;ndez-Villar A., Crespo M., Poveda E., Cabrera J. J., et al. (2022). Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci. Rep. 12, 3369. 10.1038/s41598-022-07414-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07414-x</ArticleId><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis R. H., Lunz Trujillo K., Safarpour A., Santillana M., Ognyanova K., Druckman J., et al. (2023). Association of post&#x2013;COVID-19 condition symptoms and employment status. JAMA Netw. Open 6, e2256152. 10.1001/jamanetworkopen.2022.56152</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.56152</ArticleId><ArticleId IdType="pmc">PMC9932847</ArticleId><ArticleId IdType="pubmed">36790806</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis R. H., Santillana M., Ognyanova K., Safarpour A., Lunz Trujillo K., Simonson M. D., et al. (2022). Prevalence and correlates of long COVID symptoms among U.S. Adults. JAMA Netw. Open 5, e2238804. 10.1001/jamanetworkopen.2022.38804</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D. R., Wilson D. B., Howe A., Munier C. M. L., Patel S. K., et al. (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210&#x2013;216. 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Plays M., M&#xfc;ller S., Rodriguez R. (2021). Chemistry and biology of ferritin. Metallomics 13, mfab021. 10.1093/mtomcs/mfab021</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mtomcs/mfab021</ArticleId><ArticleId IdType="pmc">PMC8083198</ArticleId><ArticleId IdType="pubmed">33881539</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J. A., Laubscher G. J., Steenkamp J., et al. (2021). Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 20, 172. 10.1186/s12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A. D., VanElzakker M. B. (2021). Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 12, 698169. 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz M. A. F., Nevesdas P. F. M., Lima S. S., Lopes J. da C., Torres M. K. da S., Vallinoto I. M. V. C., et al. (2022). Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front. Cell Infect. Microbiol. 12, 922422. 10.3389/fcimb.2022.922422</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan R. K., Kashour T., Hamid Q., Halwani R., Tleyjeh I. M. (2021). Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front. Immunol. 12, 686029. 10.3389/fimmu.2021.686029</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Risso A., Turello M., Biffoni F., Antonutto G. (2007). Red blood cell senescence and neocytolysis in humans after high altitude acclimatization. Blood Cells Mol. Dis. 38, 83&#x2013;92. 10.1016/j.bcmd.2006.10.161</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcmd.2006.10.161</ArticleId><ArticleId IdType="pubmed">17188915</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M., Rodr&#xed;guez Y., Acosta-Ampudia Y., Monsalve D. M., Zhu C., Li Q.-Z., et al. (2022). Autoimmunity is a hallmark of post-COVID syndrome. J. Transl. Med. 20, 129. 10.1186/s12967-022-03328-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa A., Pye V. E., Graham C., Muir L., Seow J., Ng K. W., et al. (2021). SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity. Sci. Adv. 7, eabg7607. 10.1126/sciadv.abg7607</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg7607</ArticleId><ArticleId IdType="pmc">PMC8163077</ArticleId><ArticleId IdType="pubmed">33888467</ArticleId></ArticleIdList></Reference><Reference><Citation>Rother R. P., Bell L., Hillmen P., Gladwin M. T. (2005). The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 293, 1653&#x2013;1662. 10.1001/jama.293.13.1653</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.293.13.1653</ArticleId><ArticleId IdType="pubmed">15811985</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo A., Tellone E., Barreca D., Ficarra S., Lagan&#xe0; G. (2022). Implication of COVID-19 on erythrocytes functionality: Red blood cell biochemical implications and morpho-functional aspects. Int. J. Mol. Sci. 23, 2171. 10.3390/ijms23042171</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23042171</ArticleId><ArticleId IdType="pmc">PMC8878454</ArticleId><ArticleId IdType="pubmed">35216286</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F. J., Hope C. M., Masavuli M. G., Lynn M. A., Mekonnen Z. A., Yeow A. E. L., et al. (2022). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. B.M.C. Med. 20, 26. 10.1186/s12916-021-02228-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa Ribero M., Jouvenet N., Dreux M., Nisole S. (2020). Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog. 16, e1008737. 10.1371/journal.ppat.1008737</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008737</ArticleId><ArticleId IdType="pmc">PMC7390284</ArticleId><ArticleId IdType="pubmed">32726355</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.-S., et al. (2022). The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 3, 100663. 10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa H. A., Shaw T. N., Knight S. B., Wemyss K., McClure F. A., Pearmain L., et al. (2021). Alterations in T and B cell function persist in convalescent COVID-19 patients. Med 2, 720&#x2013;735.e4. 10.1016/j.medj.2021.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#x142;omka A., Kowalewski M., &#x17b;ekanowska E. (2020). Coronavirus disease 2019 (COVID&#x2013;19): A short review on hematological manifestations. Pathogens 9 (6), 493. 10.3390/pathogens9060493</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9060493</ArticleId><ArticleId IdType="pmc">PMC7350358</ArticleId><ArticleId IdType="pubmed">32575786</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Grubwieser P., Sahanic S., B&#xf6;hm A. K., Pizzini A., Luger A., et al. (2022). The impact of iron dyshomeostasis and anaemia on long-term pulmonary recovery and persisting symptom burden after COVID-19: A prospective observational cohort study. Metabolites 12, 546. 10.3390/metabo12060546</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12060546</ArticleId><ArticleId IdType="pmc">PMC9228477</ArticleId><ArticleId IdType="pubmed">35736479</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K., Jamil R., Chowdhury A., Mukherjee M., Venegas C., Miyasaki K., et al. (2022). Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms. Eur. Respir. J. 61, 2200970. 10.1183/13993003.00970-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Yoon D., Christensen R. D., Horvathova M., Thiagarajan P., Prchal J. T. (2015). HIF-mediated increased R.O.S. from reduced mitophagy and decreased catalase causes neocytolysis. J. Mol. Med. 93, 857&#x2013;866. 10.1007/s00109-015-1294-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-015-1294-y</ArticleId><ArticleId IdType="pubmed">26017143</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproston N. R., Ashworth J. J. (2018). Role of C-reactive protein at sites of inflammation and infection. Front. Immunol. 9, 754. 10.3389/fimmu.2018.00754</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00754</ArticleId><ArticleId IdType="pmc">PMC5908901</ArticleId><ArticleId IdType="pubmed">29706967</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K. M., et al. (2022). Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 28, 1706&#x2013;1714. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumi T., Harada K. (2022). Immune response to SARS-CoV-2 in severe disease and long COVID-19. iScience 25, 104723. 10.1016/j.isci.2022.104723</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104723</ArticleId><ArticleId IdType="pmc">PMC9251893</ArticleId><ArticleId IdType="pubmed">35813874</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X. G., Li J. Z., Alter G., et al. (2023). Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. 76, e487&#x2013;e490. 10.1093/cid/ciac722</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Liu J., Zhang D., Xu Z., Ji J., Wen C. (2020). Cytokine storm in COVID-19: The current evidence and treatment strategies. Front. Immunol. 11, 1708. 10.3389/fimmu.2020.01708</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01708</ArticleId><ArticleId IdType="pmc">PMC7365923</ArticleId><ArticleId IdType="pubmed">32754163</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Fogarty H., Dyer A., Martin&#x2010;Loeches I., Bannan C., Nadarajan P., et al. (2021). Prolonged elevation of D&#x2010;dimer levels in convalescent COVID&#x2010;19 patients is independent of the acute phase response. J. Thrombosis Haemostasis 19, 1064&#x2013;1070. 10.1111/jth.15267</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T. K. P., Garg P., et al. (2023). Risk factors associated with post-COVID-19 condition: A systematic review and meta-analysis. JAMA Intern Med. 183, 566&#x2013;580. 10.1001/jamainternmed.2023.0750</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter C., Bezuidenhout J. A., Laubscher G. J., Lourens P. J., Steenkamp J., Kell D. B., et al. (2020). Erythrocyte, platelet, serum ferritin, and P-selectin pathophysiology implicated in severe hypercoagulation and vascular complications in COVID-19. Int. J. Mol. Sci. 21, 8234. 10.3390/ijms21218234</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218234</ArticleId><ArticleId IdType="pmc">PMC7662625</ArticleId><ArticleId IdType="pubmed">33153161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Yu C., Jing H., Wu X., Novakovic V. A., Xie R., et al. (2022). Long COVID: The nature of thrombotic sequelae determines the necessity of early anticoagulation. Front. Cell Infect. Microbiol. 12, 861703. 10.3389/fcimb.2022.861703</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Chen W., Zhang Z., Deng Y., Lian J.-Q., Du P., et al. (2020). CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct. Target Ther. 5, 283. 10.1038/s41392-020-00426-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00426-x</ArticleId><ArticleId IdType="pmc">PMC7714896</ArticleId><ArticleId IdType="pubmed">33277466</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisel J. W., Litvinov R. I. (2019). Red blood cells: The forgotten player in hemostasis and thrombosis. J. Thrombosis Haemostasis 17, 271&#x2013;282. 10.1111/jth.14360</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14360</ArticleId><ArticleId IdType="pmc">PMC6932746</ArticleId><ArticleId IdType="pubmed">30618125</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelihan M. F., Mann K. G. (2013). The role of the red cell membrane in thrombin generation. Thromb. Res. 131, 377&#x2013;382. 10.1016/j.thromres.2013.01.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2013.01.023</ArticleId><ArticleId IdType="pubmed">23402970</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams E. S., Martins T. B., Shah K. S., Hill H. R., Coiras M., Spivak A. M., et al. (2022). Cytokine deficiencies in patients with long-COVID. J. Clin. Cell Immunol. 13, 672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894377</ArticleId><ArticleId IdType="pubmed">36742994</ArticleId></ArticleIdList></Reference><Reference><Citation>Winterbourn C. C. (1995). Toxicity of iron and hydrogen peroxide: The fenton reaction. Toxicol. Lett. 82-83, 969&#x2013;974. 10.1016/0378-4274(95)03532-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-4274(95)03532-X</ArticleId><ArticleId IdType="pubmed">8597169</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Xiang M., Jing H., Wang C., Novakovic V. A., Shi J. (2023). Damage to endothelial barriers and its contribution to long COVID. Angiogenesis, 1&#x2013;18. 10.1007/s10456-023-09878-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-023-09878-5</ArticleId><ArticleId IdType="pmc">PMC10134732</ArticleId><ArticleId IdType="pubmed">37103631</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. (2022). Risks and burdens of incident diabetes in long COVID: A cohort study. Lancet Diabetes Endocrinol. 10, 311&#x2013;321. 10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. (2022). Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583&#x2013;590. 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Zhong L., Deng J., Peng J., Dan H., Zeng X., et al. (2020). High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 12, 8. 10.1038/s41368-020-0074-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41368-020-0074-x</ArticleId><ArticleId IdType="pmc">PMC7039956</ArticleId><ArticleId IdType="pubmed">32094336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J., Jiao Y., Zhang Y., Li Z., Zeng X., Deng H., et al. (2020). Hematological changes in patients with COVID-19 (Review). Mol. Med. Rep. 22, 4485&#x2013;4491. 10.3892/mmr.2020.11581</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.11581</ArticleId><ArticleId IdType="pubmed">33173966</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H.-H., Qin C., Chen M., Wang W., Tian D.-S. (2020). D-dimer level is associated with the severity of COVID-19. Thromb. Res. 195, 219&#x2013;225. 10.1016/j.thromres.2020.07.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.07.047</ArticleId><ArticleId IdType="pmc">PMC7384402</ArticleId><ArticleId IdType="pubmed">32777639</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>